*Kaori Hojo¹, Hiromiti Yamanishi², Christopher J Kline³ (1. Harima Sanatorium, 2. Hirakata Ryoiku Social welfare corporation, 3. Mayo Clinic)

*Yuki Kageyama¹, Yasuhiko Deguchi¹, Shohei Okura¹, Koki Inoue¹, Conor Liston² (1. Graduate School of Medicine, Osaka Metropolitan University, 2. Department of Psychiatry and Feil Family Brain and Mind Research Institute, Weill Cornell Medicine)

*Masahiro Ohgidani¹, Kato TA Takahiro², Tanaka Yusuke¹, Furube Eriko¹, Yoshida Shigetaka¹ (1. Department of Functional Anatomy and Neuroscience, Asahikawa Medical University, 2. Department of Neuropsychiatry Graduate School of Medical Sciences Kyushu University")

*Kazhiro Hada¹, Yoshiaki Ohi², Yuki Murata³, Kayoko Ozeki¹, Yoshifumi Wakiya¹ (1. Laboratory of Pharmacy Practice and Sciences, Aichi Gakuin University, 2. Laboratory of Neuropharmacology, School of Pharmacy, Aichi Gakuin University, 3. Laboratory of Organic and Medicinal Chemistry, School of Pharmacy, Aichi Gakuin University )

*Kenya Watanabe¹, shingen Misaka², Keiko Kanno-Nozaki³, Sae Endo¹, Yuhei Suzuki³, Yuri Koboyashi³, Shoichiro Hirata³, Mizue Ichinose³, Sho Horikoshi⁴, Takahiro Suto¹, Junko Kuroda¹, itaru Miura³ (1. Department of Pharmacy, Fukushima Medical University Hospital, 2. Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, 3. Department of Neuropsychiatry, School of Medicine, Fukushima Medical University School of Medicine, 4. HORIKOSHI psychosomatic clinic)

*Toshiharu Kamishikiryo¹, Eri Itai¹, Yuki Mitsuyama¹, Miyuki Kato¹, Go Okada¹ (1. Department of Psychiatry and Neurosciences. Graduate School of Biomedical & Health Sciences, Hiroshima University.)